Washington: An aspirin-like anti-inflammatory drug may help patients with type 2 diabetes obtain better glycemic control when added to their regular drug regime, researchers found.The scientists became interested in studying salsalate, after research conducted by Steven Shoelson, M.D., Ph.D., Head of the Section on Pathophysiology and Molecular Pharmacology and Professor of Medicine at Harvard Medical School, identified inflammation as a factor in the development of type 2 diabetes.
Moeen warned over pro-Gaza Test wristbands
ISIS opens `marriage bureau` in Syria
Farmers should get better technology: PM
Delhi shame: Class 10th student gang-raped in Uttam Nagar at gun point